NEWTON, Mass., Feb. 04, 2025 (GLOBE NEWSWIRE) -- Auron Therapeutics, a clinical-stage biotechnology company targeting cell-state plasticity to improve patient outcomes in oncology and inflammatory ...
Kate Yen is the founder and CEO of Auron Therapeutics. From the Boston Business Journal. Auron Therapeutics has raised a $27 million Series B financing that it will use to initiate clinical ...
The Newton, Massachusetts–based company Auron Therapeutics has received $48 million in series A financing from investors including DCVC Bio and Eli Lilly and Company. Auron will expand its machine ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results